BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 18495667)

  • 1. Structure of a conserved dimerization domain within the F-box protein Fbxo7 and the PI31 proteasome inhibitor.
    Kirk R; Laman H; Knowles PP; Murray-Rust J; Lomonosov M; Meziane el K; McDonald NQ
    J Biol Chem; 2008 Aug; 283(32):22325-35. PubMed ID: 18495667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of the FP domain of Fbxo7 reveals a novel mode of protein-protein interaction.
    Shang J; Wang G; Yang Y; Huang X; Du Z
    Acta Crystallogr D Biol Crystallogr; 2014 Jan; 70(Pt 1):155-64. PubMed ID: 24419388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The FP domains of PI31 and Fbxo7 have the same protein fold but very different modes of protein-protein interaction.
    Shang J; Huang X; Du Z
    J Biomol Struct Dyn; 2015; 33(7):1528-38. PubMed ID: 25266262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression, purification and crystallization of the FP domain of the human F-box protein Fbxo7.
    Shang J; Wang G; Yang Y; Huang X; Du Z
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2013 Oct; 69(Pt 10):1097-9. PubMed ID: 24100556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The E3 ubiquitin ligase SCF(Fbxo7) mediates proteasomal degradation of UXT isoform 2 (UXT-V2) to inhibit the NF-κB signaling pathway.
    Spagnol V; Oliveira CAB; Randle SJ; Passos PMS; Correia CRSTB; Simaroli NB; Oliveira JS; Mevissen TET; Medeiros AC; Gomes MD; Komander D; Laman H; Teixeira FR
    Biochim Biophys Acta Gen Subj; 2021 Jan; 1865(1):129754. PubMed ID: 33010352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond ubiquitination: the atypical functions of Fbxo7 and other F-box proteins.
    Nelson DE; Randle SJ; Laman H
    Open Biol; 2013 Oct; 3(10):130131. PubMed ID: 24107298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gsk3β and Tomm20 are substrates of the SCFFbxo7/PARK15 ubiquitin ligase associated with Parkinson's disease.
    Teixeira FR; Randle SJ; Patel SP; Mevissen TE; Zenkeviciute G; Koide T; Komander D; Laman H
    Biochem J; 2016 Oct; 473(20):3563-3580. PubMed ID: 27503909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The FBXO7 homologue nutcracker and binding partner PI31 in Drosophila melanogaster models of Parkinson's disease.
    Merzetti EM; Dolomount LA; Staveley BE
    Genome; 2017 Jan; 60(1):46-54. PubMed ID: 27936908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure and Function of Fbxo7/PARK15 in Parkinson's Disease.
    Randle SJ; Laman H
    Curr Protein Pept Sci; 2017; 18(7):715-724. PubMed ID: 26965690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of SCF ubiquitin ligases by engineered ubiquitin variants that target the Cul1 binding site on the Skp1-F-box interface.
    Gorelik M; Orlicky S; Sartori MA; Tang X; Marcon E; Kurinov I; Greenblatt JF; Tyers M; Moffat J; Sicheri F; Sidhu SS
    Proc Natl Acad Sci U S A; 2016 Mar; 113(13):3527-32. PubMed ID: 26976582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The parkinsonism-associated protein FBXO7 cooperates with the BAG6 complex in proteasome function and controls the subcellular localization of the complex.
    Wang Q; Crnković V; Preisinger C; Stegmüller J
    Biochem J; 2021 Jun; 478(12):2179-2199. PubMed ID: 34060591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis of dimerization-dependent ubiquitination by the SCF(Fbx4) ubiquitin ligase.
    Li Y; Hao B
    J Biol Chem; 2010 Apr; 285(18):13896-906. PubMed ID: 20181953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linking F-box protein 7 and parkin to neuronal degeneration in Parkinson's disease (PD).
    Zhou ZD; Sathiyamoorthy S; Angeles DC; Tan EK
    Mol Brain; 2016 Apr; 9():41. PubMed ID: 27090516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fbx7 functions in the SCF complex regulating Cdk1-cyclin B-phosphorylated hepatoma up-regulated protein (HURP) proteolysis by a proline-rich region.
    Hsu JM; Lee YC; Yu CT; Huang CY
    J Biol Chem; 2004 Jul; 279(31):32592-602. PubMed ID: 15145941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of FBXO7 (PARK15) results in reduced proteasome activity and models a parkinsonism-like phenotype in mice.
    Vingill S; Brockelt D; Lancelin C; Tatenhorst L; Dontcheva G; Preisinger C; Schwedhelm-Domeyer N; Joseph S; Mitkovski M; Goebbels S; Nave KA; Schulz JB; Marquardt T; Lingor P; Stegmüller J
    EMBO J; 2016 Sep; 35(18):2008-25. PubMed ID: 27497298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A conserved F box regulatory complex controls proteasome activity in Drosophila.
    Bader M; Benjamin S; Wapinski OL; Smith DM; Goldberg AL; Steller H
    Cell; 2011 Apr; 145(3):371-82. PubMed ID: 21529711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The F-box protein FBXO7 positively regulates bone morphogenetic protein-mediated signaling through Lys-63-specific ubiquitination of neurotrophin receptor-interacting MAGE (NRAGE).
    Kang J; Chung KC
    Cell Mol Life Sci; 2015 Jan; 72(1):181-95. PubMed ID: 24947323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Competitive binding mechanism between Skp1 and exportin 1 (CRM1) controls the localization of a subset of F-box proteins.
    Nelson DE; Laman H
    J Biol Chem; 2011 Jun; 286(22):19804-15. PubMed ID: 21378169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural analysis of a function-associated loop mutant of the substrate-recognition domain of Fbs1 ubiquitin ligase.
    Nishio K; Yoshida Y; Tanaka K; Mizushima T
    Acta Crystallogr F Struct Biol Commun; 2016 Aug; 72(Pt 8):619-26. PubMed ID: 27487926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The F-box protein Fbxo7 interacts with human inhibitor of apoptosis protein cIAP1 and promotes cIAP1 ubiquitination.
    Chang YF; Cheng CM; Chang LK; Jong YJ; Yuo CY
    Biochem Biophys Res Commun; 2006 Apr; 342(4):1022-6. PubMed ID: 16510124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.